In the sphere of immuno-oncology research, a powerful tool has emerged - the Diet-Induced Obesity (DIO) mouse model. These models provide researchers a practical route to understanding the connections between obesity, immunity, and cancer treatment. The real value of DIO mice lies in their ability to reflect human-like responses, marking a new phase of discovery. Below are the top 5 reasons researchers should be incorporating DIO mice into the preclinical evaluation of immuno-oncology treatments.
Unveiling the Potential: 5 Ways DIO Mice Enhance Immuno-Oncology Discoveries
August 22, 2023
Lost in Translation: Detection of mRNA by Flow Cytometry
By Rubina Pal PhD, Flow Cytometry Scientist
Using Flow Cytometry to Characterize Myeloid Derived Suppressor Cells (MDSC)
By Darcey L. Clark, MS DABT, Senior Biotechnology Professional
Measuring Innate Immune/Phagocytic Cell Function by Flow Cytometry
By Darcey L. Clark, MS DABT, Senior Biotechnology Professional
Get Started
Contact Us Today!
If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.